CEACAM5 and gastric cancer: Analysis of serum tumor marker levels revealed that both treatment regimens were effective in reducing serum CEA and CA199 levels in patients with advanced gastric cancer, in which the joint treatment yielded more features favoring patients' prognosis, as evidenced by the remarkably higher improvement of survival quality at follow-up in the study group than that in the control group.